Credit Agricole Upgrades Bristol-Myers Squibb (BMY) Two Notches to Outperform
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $48.42 -0.19%
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 50
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 50
Join SI Premium – FREE
Credit Agricole upgraded Bristol-Myers Squibb (NYSE: BMY) from Underperform to Outperform, price target raised from $35 to $38.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb click here. For more ratings news on Bristol-Myers Squibb click here.
Shares of Bristol-Myers Squibb closed at $34.16 yesterday.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb click here. For more ratings news on Bristol-Myers Squibb click here.
Shares of Bristol-Myers Squibb closed at $34.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades Barry Callebaut AG (BARN:SW) (BYCBF) to Buy
- RBC Capital Upgrades Admiral Group Plc. (ADM:LN) (AMIGY) to Outperform
- CIBC Upgrades Descartes (DSGX) to Outperformer
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
